'Particularly Strong' Mass-Spec Sales Help Push Thermo Fisher Q1 Revenue 19 Percent

The life science market and global stimulus funding led to growth in the company's mass spec business, CEO Marc Casper said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.